Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-BMS-FALLON-AHOD1721
StatusOPEN TO ACCRUAL
Principal InvestigatorFallon, Robert
ScopeNational
PhasePhase II
Age GroupChildren
TitleRisk-based, response-adapted, Phase II open-label trial of nivolumab + brentuximab vedotin (N + Bv) for children, adolescents, and young adults with relapsed/refractory (R/R) CD30 + classic Hodgkin lymphoma (cHL) after failure of first-line therapy, followed by brentuximab + bendamustine (Bv + B) for participants with a suboptimal response. CheckMate 744: CHECKpoint pathway and nivolumab clinical Trial Evaluation
Applicable Disease SitesHodgkin's Lymphoma
Participating InstitutionsIndiana University (IU)
  • Riley Hospital for Children
Treatment TypeTreatment
ContactMelissa Lee, Phone: 317-944-4281
Pager: 312-1228
Email: mellee@iu.edu